<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article article-type="editorial" dtd-version="1.4" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">odmj</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">OncoDaily Medical Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">ODMJ</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">3067-6444</issn>
      <publisher>
        <publisher-name>OncoDaily Medical Journal</publisher-name>
        <publisher-loc>
          <country>US</country>
        </publisher-loc>
      </publisher>
      <self-uri xlink:href="https://oncodailyjournal.com/"/>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">221</article-id>
      <article-id pub-id-type="doi">10.69690/ODMJ-003-1024-221</article-id>
      <article-categories>
        <subj-group xml:lang="en" subj-group-type="heading">
          <subject>Editorials</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Aspiring engineer who would be a cancer specialist</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Bedikian</surname>
            <given-names>Agop Y.</given-names>
          </name>
          <aff xml:lang="en">University of Texas MD Anderson Cancer Center, MD Anderson</aff>
          <email>abedikia@gmail.com</email>
          <bio xml:lang="en">
            <p>Dr. Agop Y. Bedikian is an experienced oncologist based in Houston, Texas, affiliated with the University of Texas MD Anderson Cancer Center. He earned his medical degree from the American University of Beirut Faculty of Medicine and has been practicing for several decades.</p>
          </bio>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>17</day>
        <month>10</month>
        <year>2024</year>
      </pub-date>
      <elocation-id>ODMJ-003-1024-221</elocation-id>
      <permissions>
        <copyright-statement>Copyright (c) 2024 OncoDaily Medical Journal</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>OncoDaily Medical Journal</copyright-holder>
      </permissions>
      <self-uri xlink:href="https://oncodailyjournal.com/10.69690/odmj-003-1024-221/"/>
      <kwd-group xml:lang="en">
        <kwd>Agop Y Bedikian</kwd>
        <kwd>Headlines</kwd>
        <kwd>Homepage</kwd>
        <kwd>MD Anderson Cancer Center</kwd>
        <kwd>Melanoma</kwd>
        <kwd>Oncology</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>production-ready-file-url</meta-name>
          <meta-value>
            <ext-link ext-link-type="uri" xlink:href="https://oncodailyjournal.com/pub/uploads/2024/10/Article-2.pdf"/>
          </meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body/>
  <back>
    <ref-list>
    </ref-list>
  </back>
</article>
